Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.24.1.1.u2
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock based Compensation Expense

Stock-based compensation expense is as follows:

 

    2024     2023  
    Three Months Ended  
    March 31,  
    2024     2023  
Cost of revenues   $ 12     $ 152  
Research and development     7       —  
Sales and marketing     86       46  
General and administrative     219       111  
 Stock-based compensation expenses   $ 324     $ 309  
Summary of Stock Option Activity

Stock option activity for the three months ended March 31, 2024, is set forth in the table below:

 

          Weighted     Weighted average        
          average     remaining     Aggregate  
          exercise price     contractual life     Intrinsic  
    Options     per share     (in years)     Value*  
Outstanding at January 1, 2024     5,146,382     $ 0.93                  
Granted     35,000       0.72                  
Exercised     —       —                  
Forfeited and Expired     (16,874 )     10.81                  
Outstanding at March 31, 2024     5,164,508     $ 0.89       8.64     $ 779  
Vested and Expected to Vest at March 31, 2024     5,164,508     $ 0.89       8.62     $ 779  
Exercisable at March 31, 2024     2,117,649     $ 1.49       8.50     $ 293  

 

* The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the balance sheet date.
Schedule of Outstanding Restricted Stock Units

Restricted Stock Unit (“RSU”) activity for the three months ended March 31, 2024, is set forth in the table below:

 

    RSUs  
Outstanding at January 1, 2024     681,846  
Granted     66,675  
Released     —  
Forfeited     (70,396 )
Outstanding at March 31, 2024     678,125